Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain

References

• Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 2011;27:449-62
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO's pain ladder [Internet]. 2011 [Last accessed 23 March 2011]. Available from: http://www.who.int/cancer/palliative/painladder/en/
   Google Scholar
• Davis M, Glare P, Hardy J (eds). Opioids in Cancer Pain. Oxford: Oxford University Press, 2005
   Google Scholar
• Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004;26:1808-20
   PubMed Web of Science ®Google Scholar
• Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther 2003;25:150-68
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract 2010;10:428-50
   PubMed Web of Science ®Google Scholar
• Medsafe. DBL Fentanyl Injection: datasheet [Internet]. Wellington, NZ: New Zealand Medicines and Medical Devices Safety Authority, 2008 [Last accessed 23 March 2011]. Available from: http://www.medsafe.govt.nz/profs/Datasheet/f/FentanylcitrateinjUSP.htm
   Google Scholar
• CHANGE PAIN Advisory Panel. CHANGE PAIN: opioid treatment. Aachen: Grunenthal Group, 2010
   Google Scholar
• Centre for Reviews and Dissemination. Systematic Reviews: CRD's guidance for undertaking reviews in health care [Internet]. York: University of York, 2009 [Last accessed 23 March 2011] Available from: http://www.york.ac.uk/inst/crd/SysRev/!SSL!/WebHelp/SysRev3.htm
   Google Scholar
• Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions [Internet]. Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011 [Last accessed 23 March 2011]. Available from: http://www.cochrane-handbook.org/
   Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
   PubMed Web of Science ®Google Scholar
• Puhan MA, Bachmann LM, Kliejnen J, et al. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med 2009;14:2
   Web of Science ®Google Scholar
• Pace MC, Passavanti MB, Grella E, et al. Buprenorphine in long-term control of chronic pain in cancer patients. Front Biosci 2007;12:1291-9
   PubMed Web of Science ®Google Scholar
• Böhme K, Likar R. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study Pain Clin 2003;15:193-202
   Web of Science ®Google Scholar
• Poulain P, Denier W, Douma J, et al. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. J Pain Symptom Manag 2008;36:117-25
   PubMed Web of Science ®Google Scholar
• Ahmedzai S. TTS-Fentanyl vs oral morphine in cancer pain [abstract no: 874]. Eur J Cancer 1995;31(Suppl 6):S182
   Google Scholar
• Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life. J Pain Symptom Manag 1997;13:254-61
   PubMed Web of Science ®Google Scholar
• Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-8
   PubMed Web of Science ®Google Scholar
• Allan L, Kalso E. Randomized trial of transdermal fentanyl and sustained release oral morphine in chronic low back pain. Paper presented at Pain in Europe IV. Fourth Congress of the European Federation of IASP Chapters (EFIC), 2–6 September 2003, Prague
   Google Scholar
• Allan L, Richarz U, Simpson K, et al. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine 2005;30:2484-90
   PubMed Web of Science ®Google Scholar
• Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008;12:1040-6
   PubMed Web of Science ®Google Scholar
• Öztürk T, Karadibak K, Catal D, et al. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer]. Agri Derg 2008;20:20-5
   PubMedGoogle Scholar
• van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin 2003;19:457-69
   PubMed Web of Science ®Google Scholar
• Wolff RF, Reid K, di Nissio M, et al. Systematic review of adverse events of Buprenorphine patch versus Fentanyl patch in patients with chronic moderate to severe pain. Pain Manag. Forthcoming 2012.
   Google Scholar
• Wong JO, Chiu GL, Tsao CJ, et al. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 1997;35:25-32
   Google Scholar
• Kongsgaard U, Poulain P. Transdermal fentanyl for pain control in adults with chronic cancer pain. Eur J Pain 1998;2:53-62
   PubMed Web of Science ®Google Scholar
• Kongsgaard UE, Poulain P. Transdermal fentanyl for pain control in chronic cancer pain. Support Care Cancer 1997;5(Suppl 1):177
   Google Scholar
• Langford R, McKenna F, Ratcliffe S, et al. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial. Arthritis Rheum 2006;54:1829-37
   PubMed Web of Science ®Google Scholar
• Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ 2009;338:B1147
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7(3):e1000251
   PubMed Web of Science ®Google Scholar